|
|
Volumn 8, Issue 1, 1998, Pages 9-13
|
|
Nucleic acid technology (NAT) testing and the transfusion service: a rationale for the implementation of minipool testing.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL PRODUCT;
VIRUS RNA;
BLOOD;
BLOOD DONOR;
BLOOD TRANSFUSION;
EDITORIAL;
EUROPEAN UNION;
FRACTIONATION;
GENETICS;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
ISOLATION AND PURIFICATION;
METHODOLOGY;
PLASMA;
POLYMERASE CHAIN REACTION;
PRACTICE GUIDELINE;
RISK;
SENSITIVITY AND SPECIFICITY;
STANDARD;
UNITED KINGDOM;
VIREMIA;
VIROLOGY;
BIOLOGICAL PRODUCTS;
BLOOD DONORS;
BLOOD TRANSFUSION;
CHEMICAL FRACTIONATION;
ENGLAND;
EUROPEAN UNION;
GUIDELINES;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
PLASMA;
POLYMERASE CHAIN REACTION;
RISK;
RNA, VIRAL;
SENSITIVITY AND SPECIFICITY;
VIREMIA;
|
|
EID: 0032020215
PISSN: 09587578
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-3148.1998.00130.x Document Type: Editorial |
|
Times cited : (20)
|
|
References (0)
|
